Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury

NCT00326976 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

234

Enrollment

INDUSTRY

Sponsor class

Conditions

Myocardial Ischemia
Coronary Disease
Myocardial Infarction

Interventions

DRUG: FX06
PROCEDURE: Percutaneous coronary intervention

Sponsor

Fibrex Medical Research & Development GmbH